Rajan Sharma
Stock Analyst at Goldman Sachs
(0.32)
# 4,128
Out of 4,876 analysts
5
Total ratings
25%
Success rate
-10.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $8.88 | -18.36% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $69.85 | +38.87% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $38.58 | +21.82% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $31.15 | +153.61% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $8.88
Upside: -18.36%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $69.85
Upside: +38.87%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $38.58
Upside: +21.82%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $31.15
Upside: +153.61%